Rubius Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| RTX-224 Monotherapy in Patients With Solid Tumors (NCT05219578) | Rubius Therapeutics | 2022-01-12 |
| RTX-321 Monotherapy in Patients With HPV 16+ Tumors (NCT04672980) | Rubius Therapeutics | 2021-04-08 |
| RTX-240 Monotherapy and in Combination With Pembrolizumab (NCT04372706) | Rubius Therapeutics | 2020-05-06 |
| Safety and Tolerability of RTX-134 in Adults With Phenylketonuria (NCT04110496) | Rubius Therapeutics | 2020-01-29 |
Track Rubius Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.